Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Astrocytoma”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Early research (Phase 1)Study completedNCT00024557
What this trial is testing

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 40
Testing effectiveness (Phase 2)UnknownNCT00281905
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Cancer and Leukaemia Group 50
Testing effectiveness (Phase 2)Ended earlyNCT04209790
What this trial is testing

Neoadjuvant Chemoradiation for Resectable Glioblastoma

Who this might be right for
GlioblastomaSurgeryHigh Grade Glioma
Geisinger Clinic 2
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Early research (Phase 1)Looking for participantsNCT04003649
What this trial is testing

IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM

Who this might be right for
Recurrent GlioblastomaRefractory Glioblastoma
City of Hope Medical Center 60
Early research (Phase 1)Ended earlyNCT02722512
What this trial is testing

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IIIAnaplastic Ependymoma+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 10
Testing effectiveness (Phase 2)WithdrawnNCT00984438
What this trial is testing

Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Cincinnati
Early research (Phase 1)Study completedNCT00003141
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors

Who this might be right for
Brain TumorsCentral Nervous System TumorsNeuroblastoma+1 more
Children's Oncology Group 94
Early research (Phase 1)Study completedNCT00064779
What this trial is testing

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 18
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07356973
What this trial is testing

Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma

Who this might be right for
Glioblastoma
CRISM Therapeutics LTD 147
Testing effectiveness (Phase 2)Ended earlyNCT01814813
What this trial is testing

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

Who this might be right for
Recurrent GlioblastomaRecurrent Adult Brain TumorGliosarcoma
Alliance for Clinical Trials in Oncology 90
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Early research (Phase 1)Study completedNCT01811992
What this trial is testing

Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma

Who this might be right for
Malignant GliomaGlioblastoma Multiforme
University of Michigan Rogel Cancer Center 19
Early research (Phase 1)Study completedNCT04908176
What this trial is testing

A Drug-drug Interaction Study of Avapritinib and Midazolam

Who this might be right for
Gastrointestinal Stromal TumorsGISTNon-resectable Advanced Solid Tumors+1 more
Blueprint Medicines Corporation 10
Testing effectiveness (Phase 2)Temporarily pausedNCT07301268
What this trial is testing

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Who this might be right for
Glioblastoma, IDH-WildtypeProgressive Astrocytoma, IDH-Mutant, Grade 4Progressive Glioblastoma+6 more
Mayo Clinic 36
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00005955
What this trial is testing

Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Duke University
Testing effectiveness (Phase 2)Study completedNCT00003461
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerNeuroblastoma
Duke University
Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
IDH Wildtype GlioblastomaRecurrent AstrocytomaIDH Wildtype Recurrent Glioblastoma+2 more
Jonsson Comprehensive Cancer Center 10
Load More Results